Anuh Pharma Limited (BOM:506260)

India flag India · Delayed Price · Currency is INR
92.24
-0.48 (-0.52%)
At close: Aug 6, 2025
-0.52%
Market Cap9.16B
Revenue (ttm)7.10B
Net Income (ttm)461.44M
Shares Out100.22M
EPS (ttm)4.60
PE Ratio19.84
Forward PEn/a
Dividend0.75 (0.83%)
Ex-Dividend DateAug 14, 2025
Volume32,740
Average Volume57,711
Open92.72
Previous Close92.72
Day's Range91.35 - 94.00
52-Week Range74.03 - 124.48
Beta0.26
RSI33.59
Earnings DateAug 8, 2025

About Anuh Pharma

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs. It a... [Read more]

Industry Pharmaceutical Preparations
Founded 1960
Employees 295
Stock Exchange Bombay Stock Exchange
Ticker Symbol 506260
Full Company Profile

Financial Performance

In 2024, Anuh Pharma's revenue was 6.62 billion, an increase of 2.24% compared to the previous year's 6.47 billion. Earnings were 473.52 million, a decrease of -21.16%.

Financial Statements

News

Anuh Pharma inaugurates new manufacturing block to boost capacity by 200 MT annually

Anuh Pharma Limited announced on Tuesday that it has inaugurated its new manufacturing block, INT-1A, at its facility in Tarapur, Boisar, Maharashtra. The inauguration took place on July 15, 2025, the...

25 days ago - Business Upturn